In summary, our study provides a compelling demonstration of how small molecules can be harnessed to enhance ASO activity in multiple mechanisms of action, through improved nuclear localization. The modular nature of this technology, combined with its compatibility with emerging bi-functional modalities, positions it as a promising platform for future therapeutic advancements.